A tumorigenesis threshold for endogenous Myc revealed by dosage-compensation for Myc haploinsufficiency in the absence of p53.
Bao, X.; Abdullaev, Z.; Subhendu, D. K.; Zgonc, V.; Ylaya, K.; Chung, J.-Y.; Pittaluga, S.; Hewitt, S. M.; Sedivy, J. M.; Pack, S.; Mackem, S.; Levens, D.
Show abstract
The MYC proto-oncogene is crucial for neoplasia in most tumors. Overexpressed, oncogenic MYC amplifies the flux through most major processes but does not specify a unique carcinogenic pathway. This "amplifier" model suggests that MYC must exceed an expression threshold to become oncogenic. We designed a genetic test of this model, using the mouse Trp53 null mutant (p53KO) as a highly robust tumor generator to examine the effect of a modest change in the endogenous Myc level (Myc+/-). Strikingly, tumor-free survival is greatly extended in p53KO mice with haploid Myc gene-dosage, yet in the tumors that do develop (mainly hemangiosarcomas and thymic lymphomas), their Myc deficit has been invariably compensated either by increasing Myc genomic dosage (hemangiosarcomas) or expression (lymphomas). Furthermore, acutely halving the endogenous Myc gene-dosage in established tumor allografts curtails growth rates. These results indicate that even an incremental reduction of MYC activity can be salutary in cancer and that one of the major tumor suppressor functions of p53 derives from its ability to prevent MYC overexpression. Myc generates acute DNA damage by several mechanisms and accordingly, p53s anti-Myc function may be inextricably linked to its role in genome integrity surveillance.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Defining function of wild-type and patient specific TP53 mutations in a zebrafish model of embryonal rhabdomyosarcoma 95%
- Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking LAIR-collagen interaction 94%
- Isoform-specific Disruption of the TP73 Gene Reveals a Critical Role for TAp73gamma in Tumorigenesis via Leptin 94%
Similar papers in this journal
- Multi-organ signaling mobilizes tumor-associated erythroid cells expressing immune checkpoint molecules 94%
- CHK2 inhibition provides a strategy to suppress hematological toxicity from PARP inhibitors. 94%
- DNA replication stress induced by trifluridine determines tumor cell fate according to p53 status 93%
Similar papers in this journal
- Intertumoral Genetic Heterogeneity Generates Distinct Tumor Microenvironments in a Novel Murine Synchronous Melanoma Model 94%
- Unraveling the heterogeneous mutational signature of spontaneously developing tumors in MLH1-/- mice 94%
- Transcriptomic analyses of MYCN-regulated genes in anaplastic Wilms' tumour cell lines reveals oncogenic pathways and potential therapeutic vulnerabilities 93%
Similar papers in this journal
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.